Walleye Trading’s Akero Therapeutics AKRO Stock Holding History

Walleye Trading’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,300	Closed	-$442K	–	4273
2025 Q3	$442K	Sell	9,300 -1,000	-10%	-$48.4K	﹤0.01%	2818
2025 Q2	$550K	Buy	10,300 +5,300	+106%	+$241K	﹤0.01%	2583
2025 Q1	$202K	Buy	+5,000	New	+$212K	﹤0.01%	3080
2024 Q2	–	Sell	-22,100	Closed	-$558K	–	4208
2024 Q1	$558K	Sell	22,100 -2,400	-10%	-$57.6K	﹤0.01%	2697
2023 Q4	$572K	Buy	24,500 +17,100	+231%	+$337K	﹤0.01%	2961
2023 Q3	$374K	Sell	7,400 -5,900	-44%	-$275K	﹤0.01%	3199
2023 Q2	$621K	Sell	13,300 -26,800	-67%	-$1.23M	﹤0.01%	2576
2023 Q1	$1.53M	Buy	40,100 +23,200	+137%	+$1.03M	﹤0.01%	1868
2022 Q4	$926K	Sell	16,900 -18,900	-53%	-$810K	﹤0.01%	2281
2022 Q3	$1.22M	Buy	+35,800	New	+$548K	﹤0.01%	2092

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Trading's AKRO Position: Q1 2024 in Review

Walleye Trading sold out of Akero Therapeutics (AKRO) in Q1 2024, closing a stake of 116,054 shares — an estimated $2.79M sold.

Walleye Trading first reported a position in AKRO in Q3 2022 and held it in 6 quarters. The position peaked at $5.85M in Q3 2023. 173 funds tracked by Wall St. Rank hold AKRO as of Q1 2024.

Walleye Trading reported no remaining Akero Therapeutics position as of Q1 2024 after selling out during the quarter.
Walleye Trading sold 116,054 Akero Therapeutics shares in Q1 2024, an estimated $2.79M.
Walleye Trading first reported a position in Akero Therapeutics in Q3 2022 and held it in 6 quarters.
Walleye Trading's Akero Therapeutics position peaked at $5.85M in Q3 2023.
173 funds tracked by Wall St. Rank held Akero Therapeutics as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.